Peptide Profiles — 2026-04-12
Ipamorelin is a pentapeptide (five amino acids) that has earned a reputation as the most selective growth hormone secretagogue available for research. Its specificity for GH release without significant effects on other hormones makes it a valuable research tool.
Unlike other growth hormone releasing peptides (GHRPs), ipamorelin is highly selective: - Stimulates GH release without significantly elevating cortisol - Minimal effect on prolactin levels - Does not substantially increase appetite (unlike GHRP-6) - Dose-dependent, predictable GH response
Ipamorelin acts as a ghrelin/growth hormone secretagogue receptor (GHS-R) agonist: - Binds to GHS-R in the pituitary gland - Triggers pulsatile GH release - Maintains the natural pattern of GH secretion - Works synergistically with GHRH analogs (like CJC-1295)
This remains one of the most studied peptide combinations in growth hormone research. The synergy works because: 1. CJC-1295 (no DAC) amplifies the GHRH signal 2. Ipamorelin initiates the GH pulse via the ghrelin pathway 3. Together, they produce greater GH elevation than either alone 4. The combination maintains physiological pulsatility
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.